Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice. [electronic resource]
- Molecular therapy : the journal of the American Society of Gene Therapy Jan 2015
- 7-16 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't